1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > IMS Country Review 2016: USA

IMS Country Review 2016: USA

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: USA
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 5
PRICING SYSTEM 5
REGULATORY ENVIRONMENT 5
INDUSTRY ENVIRONMENT 5
CHANNELS OF DISTRIBUTION 11
UNITED STATES DATA COLLECTION 12
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 13
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 13
FIGURE 2: AUDITED MARKET TREND 14
FIGURE 3: LEADING 35 LOCAL COMPANIES 15
FIGURE 4: LEADING 35 CORPORATIONS 17
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 19
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 21
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 22
FIGURE 8: A10C HUMAN INSULIN+ANALOGUES 22
FIGURE 9: A10J BIGUANIDE ANTIDIABETICS 23
FIGURE 10: A10P SGLT2 INHIBITOR A-DIABS 24
FIGURE 11: C10A CHOLESTandTRIGLY.REGULATOR 25
FIGURE 12: D1A ANTIFUNGALS DERMATOLOGCL 26
FIGURE 13: J5B ANTIVIRALS EXCL ANTI-HIV 27
FIGURE 14: J5C HIV ANTIVIRALS 28
FIGURE 15: L1G MAB ANTINEOPLASTICS 29
FIGURE 16: L1H PROTEIN KINASE INH A-NEO 30
FIGURE 17: L3A IMMUNOSTIM AG EX INTFRON 31
FIGURE 18: L4B ANTI-TNF PRODUCTS 32
FIGURE 19: N3A ANTI-EPILEPTICS 33
FIGURE 20: N5A ANTIPSYCHOTICS 34
FIGURE 21: P1D ANTI-MALARIALS 35
FIGURE 22: R7X ALL OTH RESP SYST PRODS 36
FIGURE 23: LEADING 40 PRODUCTS 37
FIGURE 24: LEADING 40 NEW PRODUCTS 39
FIGURE 25: LEADING 15 PRODUCT FORMS 42
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 43
SECTION 3: APPENDICES 45
APPENDIX 1: AUDITED UNIVERSE 45
APPENDIX 2: COUNTRY SPECIFIC ALERTS 46
APPENDIX 3: MEASURE INDEX 49
APPENDIX 4: SALES DATA MEASURES 51
APPENDIX 5: *LATEST FACTORS 53
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 57
APPENDIX 7: CORPORATIONS 59
APPENDIX 8: PRODUCT NAMES 60
APPENDIX 9: THERAPIES 62
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 63
IMS Country R

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 US Ancillary Hospital Locations (ER, OR, ICU, CCU) Diagnostics Market--Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

2017-2021 US Critical Care Diagnostics Market in Ancillary Hospital Locations (ERs, ORs, ICU/CCUs): Test Volume and Sales Segment Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of ...

2017 US Hematology and Flow Cytometry Market: Hospitals, Commercial Laboratories, POC Locations

2017 US Hematology and Flow Cytometry Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.